Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Leber's hereditary optic neuropathy is a maternally inherited disease resulting in optic nerve degeneration and cardiac dysrhythmia. A mitochondrial DNA replacement mutation was identified that correlated with this disease in multiple families. This mutation converted a highly conserved arginine to a histidine at codon 340 in the NADH dehydrogenase subunit 4 gene and eliminated an Sfa NI site, thus providing a simple diagnostic test. This finding demonstrated that a nucleotide change in a mitochondrial DNA energy production gene can result in a neurological disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The m.11778G>A mutation causes a severe clinical form of LHON, with multiple natural history studies in MT-ND4 LHON patients confirming rare and poor recovery, although younger age at onset, especially onset at less than 12 years, portends a relatively better visual prognosis.2,3,6”
From Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy (2023) · cites this paper as [6]
Citations
Cites
Sequence and organization of the human mitochondrial genome
Anderson, S., Bankier, A. T., Barrell, B. G., de Bruijn, M. H. L., Coulson, A. R., Drouin, J., Eperon, I. C., Nierlich, D. P., Roe, B. A., Sanger, F., et al. (1981) · Nature · doi:10.1038/290457a0 · Cited by 9,636
Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., & Arnheim, N. (1985) · Science · doi:10.1126/science.2999980 · Cited by 8,956
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing
Sanger, F., Coulson, A. R., Barrell, B. G., Smith, A. J. H., & Roe, B. A. (1980) · Journal of Molecular Biology · doi:10.1016/0022-2836(80)90196-5 · Cited by 3,407
Mitochondrial DNA and human evolution
Cann, R. L., Stoneking, M., & Wilson, A. C. (1987) · Nature · doi:10.1038/325031a0 · Cited by 3,100
Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies
Holt, I. J., Harding, A. E., & Morgan-Hughes, J. A. (1988) · Nature · doi:10.1038/331717a0 · Cited by 1,846
Sequence and gene organization of mouse mitochondrial DNA
Bibb, M. J., Van Etten, R. A., Wright, C. T., Walberg, M. W., & Clayton, D. A. (1981) · Cell · doi:10.1016/0092-8674(81)90300-7 · Cited by 1,710
Mitochondrial DNA sequences of primates: tempo and mode of evolution
Brown, W. M., Prager, E. M., Wang, A., & Wilson, A. C. (1982) · Journal of Molecular Evolution · doi:10.1007/bf01734101 · Cited by 1,554
Anderson, S., de Bruijn, M. H. L., Coulson, A. R., Eperon, I. C., Sanger, F., & Young, I. G. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90137-1 · Cited by 1,472
Maternal inheritance of human mitochondrial DNA.
Giles, R. E., Blanc, H., Cann, H. M., & Wallace, D. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6715 · Cited by 1,365
Self-citationDeletions of mitochondrial DNA in Kearns‐Sayre syndrome
Zeviani, M., Moraes, C. T., DiMauro, S., Nakase, H., Bonilla, E., Schon, E. A., & Rowland, L. P. (1988) · Neurology · doi:10.1212/wnl.38.9.1339 · Cited by 735
Research works printed but not linked: 3
- LESTIENNE, P, KEARNS-SAYRE SYNDROME WITH MUSCLE MITOCHONDRIAL-DNA DELETION, LANCET 1: 885 (1988).
- WALLACE, D.C., BIRTH DEFECTS 23: 137 (1987).
- Went, L. N., Handbook of Clinical Neurology 13: 94 (1972).
Cited by
Items 101–200 of 1,011
An ND-6 mitochondrial DNA mutation associated with leber hereditary optic neuropathy
Johns, D. R., Neufeld, M. J., & Park, R. D. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90479-5 · Cited by 347
Mitochondrial genetic medicine
Wallace, D. C. (2018) · Nature Genetics · doi:10.1038/s41588-018-0264-z · Cited by 345
Self-citationA mitochondrial bioenergetic etiology of disease
Wallace, D. C. (2013) · Journal of Clinical Investigation · doi:10.1172/jci61398 · Cited by 342
Self-citationMackey, D. A., Oostra, R., Rosenberg, T., Nikoskelainen, E. K., Brontë-Stewart, J., Poulton, J., Harding, A. E., Govan, G. G., Bolhuis, P. A., & Nørby, S. (1996) · PubMed Central · Cited by 339
Self-citationMitochondrial DNA repair and aging
Mandavilli, B. S., Santos, J. H., & Van Houten, B. (2002) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00220-8 · Cited by 338
Oxidative Phosphorylation Diseases: Disorders of Two Genomes
Shoffner, J. M., & Wallace, D. C. (1990) · Advances in Human Genetics · doi:10.1007/978-1-4757-9065-8_5 · Cited by 336
Self-citationGardner, A., & Boles, R. G. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.030 · Cited by 333
“The first pathogenic mtDNA mutations that could be linked to specific disorders were reported in 1988 (Holt et al., 1988; Lestienne and Ponsot, 1988;Wallace et al., 1988; Zeviani et al., 1988). mtDNA is inherited only from the ova, and hence is transmitted in the maternal line.”
BackgroundMitochondrial DNA: Distribution, Mutations, and Elimination
Yan, C., Duanmu, X., Zeng, L., Liu, B., & Song, Z. (2019) · Cells · doi:10.3390/cells8040379 · Cited by 328
Mitochondrial oxidative phosphorylation defects in parkinson's disease
Shoffner, J. M., Watts, R. L., Juncos, J. L., Torroni, A., & Wallace, D. C. (1991) · Annals of Neurology · doi:10.1002/ana.410300304 · Cited by 333
Self-citationLinkage Disequilibrium and Recombination in Hominid Mitochondrial DNA
Awadalla, P., Eyre-Walker, A., & Smith, J. M. (1999) · Science · doi:10.1126/science.286.5449.2524 · Cited by 337
Targeting Mitochondria with Organelle‐Specific Compounds: Strategies and Applications
Yousif, L. F., Stewart, K. M., & Kelley, S. O. (2009) · ChemBioChem · doi:10.1002/cbic.200900185 · Cited by 330
Mitochondrial DNA mutations in disease and aging
Park, C. B., & Larsson, N.-G. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201010024 · Cited by 277
Mitochondria and cancer chemoresistance
Guerra, F., Arbini, A. A., & Moro, L. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.012 · Cited by 323
Psychological Stress and Mitochondria: A Conceptual Framework
Picard, M., & McEwen, B. S. (2018) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000544 · Cited by 307
Complex I deficiency: clinical features, biochemistry and molecular genetics
Fassone, E., & Rahman, S. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101159 · Cited by 320
Jun, A. S., Brown, M. D., & Wallace, D. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.6206 · Cited by 317
Self-citationA neurological perspective on mitochondrial disease
McFarland, R., Taylor, R. W., & Turnbull, D. M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70116-2 · Cited by 316
Czarny, P., Wigner, P., Galecki, P., & Sliwinski, T. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.036 · Cited by 310
“Therefore, damage to mtDNA may lead to mitochondrial dysfunction and pathological states [Holt et al. 1988; Lestienne and Ponsot 1988; Wallace et al. 1988].”
BackgroundComplex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage
Perier, C., Tieu, K., Guégan, C., Caspersen, C., Jackson-Lewis, V., Carelli, V., Martinuzzi, A., Hirano, M., Przedborski, S., & Vila, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508215102 · Cited by 308
Fearnley, I. M., & Walker, J. E. (1992) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(92)90001-i · Cited by 311
Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo
Gammage, P. A., Viscomi, C., Simard, M.-L., Costa, A. S. H., Gaude, E., Powell, C. A., Van Haute, L., McCann, B. J., Rebelo-Guiomar, P., Cerutti, R., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0165-9 · Cited by 303
Holt, I. J., Harding, A. E., Cooper, J. M., Schapira, A. H. V., Toscano, A., Clark, J. B., & Morgan‐Hughes, J. A. (1989) · Annals of Neurology · doi:10.1002/ana.410260603 · Cited by 305
Mitochondrial disorders of the OXPHOS system
Fernandez‐Vizarra, E., & Zeviani, M. (2021) · FEBS Letters · doi:10.1002/1873-3468.13995 · Cited by 305
The development of mitochondrial medicine.
Luft, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8731 · Cited by 300
Mitochondrial DNA variation and cancer
Kopinski, P. K., Singh, L. N., Zhang, S., Lott, M. T., & Wallace, D. C. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00358-w · Cited by 301
Self-citationGreaves, L. C., Reeve, A. K., Taylor, R. W., & Turnbull, D. M. (2012) · The Journal of Pathology · doi:10.1002/path.3028 · Cited by 302
Chomyn, A., Meola, G., Bresolin, N., Lai, S. T., Scarlato, G., & Attardi, G. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.2236 · Cited by 301
The Texas Cytoplasm of Maize: Cytoplasmic Male Sterility and Disease Susceptibility
Levings, C. S. (1990) · Science · doi:10.1126/science.250.4983.942 · Cited by 298
Meyer, E. H., Tomaz, T., Carroll, A. J., Estavillo, G., Delannoy, E., Tanz, S. K., Small, I. D., Pogson, B. J., & Millar, A. H. (2009) · Plant Physiology · doi:10.1104/pp.109.141770 · Cited by 301
Recent Advances in Mitochondrial Disease
Craven, L., Alston, C. L., Taylor, R. W., & Turnbull, D. M. (2017) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091416-035426 · Cited by 288
Threshold Effect and Tissue Specificity
Rossignol, R., Malgat, M., Mazat, J.-P., & Letellier, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33426 · Cited by 288
Mitochondria and Cancer: Warburg Addressed
WALLACE, D. C. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.035 · Cited by 285
Self-citationMitochondrial medicine in the omics era
Rahman, J., & Rahman, S. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30727-x · Cited by 283
St. John, J. C., Facucho-Oliveira, J., Jiang, Y., Kelly, R., & Salah, R. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq002 · Cited by 282
The First Nuclear-Encoded Complex I Mutation in a Patient with Leigh Syndrome
Loeffen, J., Smeitink, J., Triepels, R., Smeets, R., Schuelke, M., Sengers, R., Trijbels, F., Hamel, B., Mullaart, R., & van den Heuvel, L. (1998) · The American Journal of Human Genetics · doi:10.1086/302154 · Cited by 285
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis
Witte, M. E., Mahad, D. J., Lassmann, H., & van Horssen, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.11.007 · Cited by 278
Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson's disease
Hattori, N., Tanaka, M., Ozawa, T., & Mizuno, Y. (1991) · Annals of Neurology · doi:10.1002/ana.410300409 · Cited by 276
Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy
Guy, J., Qi, X., Pallotti, F., Schon, E. A., Manfredi, G., Carelli, V., Martinuzzi, A., Hauswirth, W. W., & Lewin, A. S. (2002) · Annals of Neurology · doi:10.1002/ana.10354 · Cited by 215
The Significance of Biology for Human Development: A Developmental Psychobiological Systems View
Gottlieb, G., Wahlsten, D., & Lickliter, R. (2007) · Handbook of Child Psychology · doi:10.1002/9780470147658.chpsy0105 · Cited by 274
Mammalian Mitochondria Possess Homologous DNA Recombination Activity
Thyagarajan, B., Padua, R. A., & Campbell, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27536 · Cited by 272
Genetics of mitochondrial diseases: Identifying mutations to help diagnosis
Stenton, S. L., & Prokisch, H. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102784 · Cited by 264
Mitochondrial DNA complex I and III mutations associated with Leber's hereditary optic neuropathy.
Brown, M. D., Voljavec, A. S., Lott, M. T., Torroni, A., Yang, C. C., & Wallace, D. C. (1992) · Genetics · doi:10.1093/genetics/130.1.163 · Cited by 272
Self-citationA century of mitochondrial research: achievements and perspectives
Scheffler, I. E. (2001) · Mitochondrion · doi:10.1016/s1567-7249(00)00002-7 · Cited by 268
Clinical and molecular findings in children with complex I deficiency
Bugiani, M., Invernizzi, F., Alberio, S., Briem, E., Lamantea, E., Carrara, F., Moroni, I., Farina, L., Spada, M., Donati, M. A., et al. (2004) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2004.09.006 · Cited by 264
“The same CGC codon, encoding an R residue, is affected by the 11778GNA mutation, which is commonly associated with Leber’s hereditary optic neuropathy (LHON) [22].”
BackgroundPapa, S. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00077-1 · Cited by 266
Wallace, D. C. (1995) · PubMed · Cited by 264
Self-citationHattori, K., Tanaka, M., Sugiyama, S., Obayashi, T., Ito, T., Satake, T., Hanaki, Y., Asai, J., Nagano, M., & Ozawa, T. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90020-i · Cited by 262
Local translation of extranuclear lamin B promotes axon maintenance
Yoon, B. C., Jung, H., Dwivedy, A., O'Hare, C. M., Zivraj, K. H., & Holt, C. E. (2012) · Cell · doi:10.1016/j.cell.2011.11.064 · Cited by 263
“Mitochondrial function is essential for numerous processes required to maintain axonal health and stability (Knott et al., Cell 148, 752–764, February 17, 2012 ª2012 Elsevier Inc. 761 2008), and accumulating evidence points to mitochondrial dysfunction as one of the main causes in some neurodegenerative diseases, incl…”
BackgroundInfluentialA comprehensive review of retinal gene therapy
Boye, S. E., Boye, S. L., Lewin, A. S., & Hauswirth, W. W. (2013) · Molecular Therapy · doi:10.1038/mt.2012.280 · Cited by 262
Mitochondrial disorders: prevalence, myths and advances
Thorburn, D. R. (2004) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000031098.41409.55 · Cited by 258
“OXPHOS disorders were first recognized 40 years ago (Luft et al 1962), and the discovery of pathogenic mitochondrial DNA (mtDNA) mutations in the late 1980s (Holt et al 1988; Wallace et al 1988) explained the maternal inheritance pattern seen in some mitochondrial diseases.”
BackgroundBrown, M. D., Torroni, A., Reckord, C. L., & Wallace, D. C. (1995) · Human Mutation · doi:10.1002/humu.1380060405 · Cited by 256
Self-citationMitochondria: a hub of redox activities and cellular distress control
Kakkar, P., & Singh, B. K. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9520-8 · Cited by 255
OXPHOS mutations and neurodegeneration
Koopman, W. J. H., Distelmaier, F., Smeitink, J. A., & Willems, P. H. (2013) · The EMBO Journal · doi:10.1038/emboj.2012.300 · Cited by 254
Mitochondrial DNA Variation in Human Radiation and Disease
Wallace, D. C. (2015) · Cell · doi:10.1016/j.cell.2015.08.067 · Cited by 256
Self-citationMitochondrial energy generation disorders: genes, mechanisms, and clues to pathology
Frazier, A. E., Thorburn, D. R., & Compton, A. G. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.809194 · Cited by 257
Oestrogens ameliorate mitochondrial dysfunction in Leber’s hereditary optic neuropathy
Giordano, C., Montopoli, M., Perli, E., Orlandi, M., Fantin, M., Ross-Cisneros, F. N., Caparrotta, L., Martinuzzi, A., Ragazzi, E., Ghelli, A., et al. (2011) · Brain · doi:10.1093/brain/awq276 · Cited by 252
Leber's Hereditary Optic Neuropathy: Clinical Manifestations of the 3460 Mutation
Johns, D. R. (1992) · Archives of Ophthalmology · doi:10.1001/archopht.1992.01080230077025 · Cited by 247
The Neuro-ophthalmology of Mitochondrial Disease
Fraser, J. A., Biousse, V., & Newman, N. J. (2010) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2009.10.002 · Cited by 249
Mitochondrial diseases: from molecular mechanisms to therapeutic advances
Wen, H., Deng, H., Li, B., Chen, J., Zhu, J., Zhang, X., Yoshida, S., & Zhou, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02044-3 · Cited by 222
HIONA, A. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2007.10.001 · Cited by 247
Leber's Hereditary Optic Neuropathy: New Genetic Considerations
Newman, N. J. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540050082021 · Cited by 218
Moraes, C. T., Ricci, E., Bonilla, E., DiMauro, S., & Schon, E. A. (1992) · PubMed · Cited by 246
White, T. J., Arnheim, N., & Erlich, H. A. (1989) · Trends in Genetics · doi:10.1016/0168-9525(89)90073-5 · Cited by 226
The structure of human mitochondrial DNA variation
Merriwether, D. A., Clark, A. G., Ballinger, S. W., Schurr, T. G., Soodyall, H., Jenkins, T., Sherry, S. T., & Wallace, D. C. (1991) · Journal of Molecular Evolution · doi:10.1007/bf02102807 · Cited by 243
Self-citationIdebenone Treatment In Leber's Hereditary Optic Neuropathy
Carelli, V., La Morgia, C., Valentino, M. L., Rizzo, G., Carbonelli, M., De Negri, A. M., Sadun, F., Carta, A., Guerriero, S., Simonelli, F., et al. (2011) · Brain · doi:10.1093/brain/awr180 · Cited by 241
Uittenbogaard, M., & Chiaramello, A. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140305224906 · Cited by 239
Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders
Carelli, V., La Morgia, C., Valentino, M. L., Barboni, P., Ross-Cisneros, F. N., & Sadun, A. A. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.02.024 · Cited by 236
Howell, N., Kubacka, I., Xu, M., & McCullough, D. A. (1991) · PubMed · Cited by 237
Sánchez‐Céspedes, M., Parrella, P., Nomoto, S., Cohen, D., Xiao, Y. Q., Esteller, M., Jerónimo, C., Jordan, R. C. K., Nicol, T. L., Koch, W. M., et al. (2001) · PubMed · Cited by 262
Mitochondrial dysfunction: A potential link between neuroinflammation and neurodegeneration?
Witte, M. E., Geurts, J. J. G., de Vries, H. E., van der Valk, P., & van Horssen, J. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.05.014 · Cited by 235
Neuroimaging of mitochondrial disease
Saneto, R. P., Friedman, S. D., & Shaw, D. W. W. (2008) · Mitochondrion · doi:10.1016/j.mito.2008.05.003 · Cited by 235
Mitochondrial Medicine: Pharmacological targeting of mitochondria in disease
Armstrong, J. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707288 · Cited by 234
Facucho-Oliveira, J. M., & St. John, J. C. (2009) · Stem Cell Reviews and Reports · doi:10.1007/s12015-009-9058-0 · Cited by 235
Mouse mtDNA mutant model of Leber hereditary optic neuropathy
Lin, C. S., Sharpley, M. S., Fan, W., Waymire, K. G., Sadun, A. A., Carelli, V., Ross-Cisneros, F. N., Baciu, P., Sung, E., McManus, M. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217113109 · Cited by 228
Self-citationGene Therapy for Leber Hereditary Optic Neuropathy
Feuer, W. J., Schiffman, J. C., Davis, J. L., Porciatti, V., Gonzalez, P., Koilkonda, R. D., Yuan, H., Lalwani, A., Lam, B. L., & Guy, J. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.10.025 · Cited by 230
“In 1988, a G to A transition at nt-11778 in the ND4 subunit gene of complex I of mtDNA was first linked to the blindness of Leber hereditary optic neuropathy (LHON).(1) The clinical features of LHON were described a century earlier.”
BackgroundMolecular Genetics of Human Retinal Disease
Rattner, A., Sun, H., & Nathans, J. (1999) · Annual Review of Genetics · doi:10.1146/annurev.genet.33.1.89 · Cited by 228
Carelli, V., Carbonelli, M., de Coo, I. F., Kawasaki, A., Klopstock, T., Lagrèze, W. A., La Morgia, C., Newman, N. J., Orssaud, C., Pott, J. W. R., et al. (2017) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000570 · Cited by 228
Luján-Huertas, S. (2005) · Angiología · doi:10.1016/s0003-3170(05)74921-x · Cited by 224
Mackey, D. A., & Howell, N. (1992) · PubMed · Cited by 225
Mitochondrial DNA mutations in human degenerative diseases and aging
Wallace, D. C., Shoffner, J. M., Trounce, I., Brown, M. D., Ballinger, S. W., Corral-Debrinski, M., Horton, T., Jun, A. S., & Lott, M. T. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00021-u · Cited by 227
Self-citationEllouze, S., Augustin, S., Bouaita, A., Bonnet, C., Simonutti, M., Forster, V., Picaud, S., Sahel, J.-A., & Corral-Debrinski, M. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.08.013 · Cited by 222
Mitonuclear interactions: evolutionary consequences over multiple biological scales
Wolff, J. N., Ladoukakis, E. D., Enríquez, J. A., & Dowling, D. K. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0443 · Cited by 222
Newman, N. J., & Biousse, V (2004) · Eye · doi:10.1038/sj.eye.6701591 · Cited by 210
Diseases caused by defects of mitochondrial carriers: A review
Palmieri, F. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.03.008 · Cited by 221
Wallace, D. C., Stugard, C., Murdock, D., Schurr, T., & Brown, M. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14900 · Cited by 219
Self-citationEpidemiology and penetrance of Leber hereditary optic neuropathy in Finland
Puomila, A., Hämäläinen, P., Kivioja, S., Savontaus, M.-L., Koivumäki, S., Huoponen, K., & Nikoskelainen, E. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201828 · Cited by 213
Self-citationTaivassalo, T., Shoubridge, E. A., Chen, J., Kennaway, N. G., DiMauro, S., Arnold, D. L., & Haller, R. G. (2001) · Annals of Neurology · doi:10.1002/ana.1050 · Cited by 212
Making Proteins in the Powerhouse
Hällberg, B. M., & Larsson, N.-G. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.001 · Cited by 215
Nonneutral Mitochondrial DNA Variation in Humans and Chimpanzees
Nachman, M. W., Brown, W. M., Stoneking, M., & Aquadro, C. F. (1996) · Genetics · doi:10.1093/genetics/142.3.953 · Cited by 219
Hereditary optic neuropathies: from the mitochondria to the optic nerve.
Newman, N. J. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.03.017 · Cited by 209
Mitochondrial DNA mutations and neuromuscular disease
Wallace, D. C. (1989) · Trends in Genetics · doi:10.1016/0168-9525(89)90005-x · Cited by 212
Self-citationAvise, J. C. (1991) · Annual Review of Genetics · doi:10.1146/annurev.ge.25.120191.000401 · Cited by 210
Mitochondrial defects in cardiomyopathy and neuromuscular disease
Wallace, D. C. (2000) · American Heart Journal · doi:10.1067/mhj.2000.103934 · Cited by 208
Self-citationFinsterer, J. (2004) · European Journal of Neurology · doi:10.1046/j.1351-5101.2003.00728.x · Cited by 206
Mitochondria as targets for detection and treatment of cancer
Modica-Napolitano, J. S., & Singh, K. (2002) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399402004453 · Cited by 207
Gene Therapy for Leber Hereditary Optic Neuropathy
Guy, J., Feuer, W. J., Davis, J. L., Porciatti, V., Gonzalez, P. J., Koilkonda, R. D., Yuan, H., Hauswirth, W. W., & Lam, B. L. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.05.016 · Cited by 204
Mitochondria in Neurodegeneration
Lezi, E., & Swerdlow, R. H. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-007-2869-1_12 · Cited by 198
Smits, P., Smeitink, J., & van den Heuvel, L. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/737385 · Cited by 202
“Nonetheless, since the discovery of the first mtDNA mutations associated with mitochondrial disorders in 1988 [208, 209], numerous mutations in mtDNA and nDNA have been reported and the list is still expanding (for an overview see e.”
BackgroundDQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells
D’Souza, G. G. M., Rammohan, R., Cheng, S.-M., Torchilin, V. P., & Weissig, V. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00297-9 · Cited by 203
Hämäläinen, R. H., Manninen, T., Koivumäki, H., Kislin, M., Otonkoski, T., & Suomalainen, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311660110 · Cited by 203
Metadata
- Authors
- Wallace, D. C., Singh, G., Lott, M. T., Hodge, J. A., Schurr, T. G., Lezza, A. M. S., Elsas, L. J., & Nikoskelainen, E. K.
- Affiliations
- Emory University (US)
- Departments of Biochemistry and Pediatrics, Division of Medical Genetics, Emory University School of Medicine, Atlanta, GA 30322.
- Turku University Hospital (FI)
- Venue
- Science
- Published
- 1988-12-09
- Volume
- 242
- Issue
- 4884
- Pages
- 1427-1430
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2017347785
- Cited by
- 2,440
- References
- 39
- Citations by year
- 2026: 41 · 2025: 53 · 2024: 61 · 2023: 63 · 2022: 98 · 2021: 83 · 2020: 77 · 2019: 81 · 2018: 91 · 2017: 77 · 2016: 61 · 2015: 62 · 2014: 65 · 2013: 71 · 2012: 74
- FWCI
- 17.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS-21328)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- Leber's hereditary optic neuropathy, mitochondrial DNA mutations, maternally inherited disease, NADH dehydrogenase subunit 4, ND4 gene, optic nerve degeneration, cardiac arrhythmias, genetic diagnosis
- MeSH terms
- Animals, Arginine, Black or African American, Cytochrome Reductases, DNA, Mitochondrial, Female, Genes, Georgia, Histidine, Humans, Male, Mutation, NADH Dehydrogenase, Pedigree, Reference Values, Hereditary Sensory and Motor Neuropathy, Optic Atrophies, Hereditary, Black People, White People, Macromolecular Substances
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.